IL10 and neoplasm: They found that ACT of tumour antigen-specific PMEL CD8+ T cells with IL-10-Fc enhanced tumour infiltration of TILs and increased the number of CD8+ T cells with minimal impact on other lymphocytes or myeloid cells.